Daten zu öffentlichen Aufträgen und Fördermitteln in Europa aus amtlichen Registern · Datenstand: 17. November 2026, tägliche Aktualisierung.

Förderprogramm · Vereinigte Staaten

Extramural Research Programs in the Neurosciences and Neurological Disorders

Extramural Research Programs in the Neurosciences and Neurological Disorders (Vereinigte Staaten): Aufrufe und Förderungen des Programms. 129 Aufrufe auf der Seite, davon 36 offen; Aufrufe starten meist im November. Datenstand: 17. November 2026, tägliche Aktualisierung.

Fördergeber: National Institutes of Health (Department of Health and Human Services)

Förderungen der letzten 24 Monate
0
Empfänger
0
Offene Aufrufe
36
Aufrufe auf der Seite
129

Aufrufe starten meist im November

Über das Programm

Objectives: (1) To support extramural research funded by the National Institute of Neurological Disorders and Stroke (NINDS) including: basic research that explores the fundamental structure and function of the brain and the nervous system; research to understand the causes and origins of…

Mehr in der Quelle

Offene Aufrufe

FörderaufrufStatusFrist
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) (Runde 11.2024 – 11.2026)Offen19. November 2026
Translational Neural Devices (R61/R33 - Clinical Trial Optional) (Runde 10.2024 – 01.2027)Offen28. Januar 2027
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) (Runde 12.2024 – 10.2027)Offen8. Oktober 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)Offen20. Oktober 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) (Runde 10.2024 – 10.2027)Offen20. Oktober 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) (Runde 11.2024 – 10.2027)Offen20. Oktober 2027
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)Offen5. November 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) (Runde 12.2024 – 11.2027)Offen12. November 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) (Runde 12.2024 – 11.2027)Offen12. November 2027
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)Offen7. Januar 2028
NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)Offen9. März 2029
NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure – National Coordinating Center (NCC) and National Data Management Center (NDMC)Geplant—
Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)Geplant—
Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Coordinating Center (CCC) & Data Coordinating Center (DCC)Geplant—
Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)Geplant—
HEAL Initiative: Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins and the Nature of (PRECISION) Human Pain NetworkGeplant—
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Coordinating Center (CCC) and Data Coordinating Center (DCC)Geplant—
HEAL Initiative: Optimization of Therapeutic Medical Devices through Team Science Mechanistic Research (RM1)Geplant—
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent IdentificationGeplant—
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and DevelopmentGeplant—
Undiagnosed Diseases Network (UDN) Diagnostic Research Innovation CenterGeplant—
Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral SciencesGeplant—
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)Geplant—
Undiagnosed Diseases Network (UDN) Clinical and Data Coordinating CenterGeplant—
Forecast for NIH Blueprint and BRAIN Initiative ACTION Potential Program (F99/K00 Clinical Trial Not Allowed)Geplant—
NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure – Regional Coordinating Stroke Centers (RCCs)Geplant—
Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)Geplant—
Functional Target Validation for Alzheimer's Disease-Related DementiasGeplant—
Undiagnosed Diseases Network (UDN) Clinical Networks of Diagnostic ExcellenceGeplant—
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection – Network Sites and Coordinating Center (U01- CT Not Allowed)Geplant—

Förderkalender

Förderungen für Projekte mit Beginn zwischen 17. November 2024 und 17. November 2026; Beträge in Euro zum Eurostat-Kurs des jeweiligen Jahres.

Fragen und Antworten

Extramural Research Programs in the Neurosciences and Neurological Disorders: Wann starten die Förderaufrufe?
Derzeit offen (36): NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and P… (19. November 2026), Translational Neural Devices (R61/R33 - Clinical Trial Optional) (28. Januar 2027), Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neu… (8. Oktober 2027), …. Aufrufe starten meist im November.